Partnering Overview

TRACON Pharmaceuticals seeks to develop, manufacture, and commercialize its products on a global basis through collaborative, open relationships with partners. The company is specifically interested in evaluating late preclinical and clinical stage compounds with the potential to treat cancer and eye disease, and actively searches out and responds to oncology in-licensing opportunities. TRACON has experience collaborating with public pharmaceutical companies, as well as academic institutions.

To explore opportunities to partner with TRACON Pharmaceuticals, please contact Business Development.